Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 761-772
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.761
Table 2 Tumor and clinical characteristics
| Characteristics | 2010-2014, 154 patients | 2015-2019, 174 patients | All patients, 328 |
| BCLC stage, n (%) | |||
| BCLC 0 | 4 (3) | 8 (5) | 12 (4) |
| BCLC A | 47 (31) | 58 (33) | 105 (32) |
| BCLC B | 31 (20) | 43 (25) | 74 (23) |
| BCLC C | 56 (36) | 57 (33) | 113 (34) |
| BCLC D | 16 (10) | 8 (5) | 24 (7) |
| Child-Pugh stage, n (%) | |||
| Class A | 114 (74) | 133 (76) | 247 (75) |
| Class B | 30 (19) | 38 (22) | 68 (21) |
| Class C | 10 (6) | 3 (2) | 13 (4) |
| MELD score, mean ± SD | 10.7 ± 3.8 | 10.4 ± 3.6 | 10.4 ± 3.6 |
| Nodule characteristics, n (%) | |||
| Unifocal | 65 (42) | 75 (43) | 140 (43) |
| Paucifocal | 24 (16) | 40 (23) | 64 (20) |
| Multifocal | 52 (34) | 40 (23) | 92 (28) |
| Infiltrative/massive | 13 (8) | 19 (11) | 32 (10) |
| Dimension in cm, mean ± SD | 4.3 ± 2.9 | 4.9 ± 3.3 | 4.6 ± 3.1 |
- Citation: Bracco C, Gallarate M, Badinella Martini M, Magnino C, D'Agnano S, Canta R, Racca G, Melchio R, Serraino C, Polla Mattiot V, Gollè G, Fenoglio L. Epidemiology, therapy and outcome of hepatocellular carcinoma between 2010 and 2019 in Piedmont, Italy. World J Gastrointest Oncol 2024; 16(3): 761-772
- URL: https://www.wjgnet.com/1948-5204/full/v16/i3/761.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.761